| Product Code: ETC9556526 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Vasudha | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Sweden Heart Failure Diagnostics/Therapeutics Market Overview |
3.1 Sweden Country Macro Economic Indicators |
3.2 Sweden Heart Failure Diagnostics/Therapeutics Market Revenues & Volume, 2021 & 2031F |
3.3 Sweden Heart Failure Diagnostics/Therapeutics Market - Industry Life Cycle |
3.4 Sweden Heart Failure Diagnostics/Therapeutics Market - Porter's Five Forces |
3.5 Sweden Heart Failure Diagnostics/Therapeutics Market Revenues & Volume Share, By Therapy, 2021 & 2031F |
3.6 Sweden Heart Failure Diagnostics/Therapeutics Market Revenues & Volume Share, By Product, 2021 & 2031F |
3.7 Sweden Heart Failure Diagnostics/Therapeutics Market Revenues & Volume Share, By Tests, 2021 & 2031F |
4 Sweden Heart Failure Diagnostics/Therapeutics Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of heart failure in Sweden |
4.2.2 Technological advancements in diagnostic tools and therapeutic options |
4.2.3 Growing awareness about early detection and treatment of heart failure |
4.3 Market Restraints |
4.3.1 Stringent regulatory requirements for approval of diagnostic and therapeutic products |
4.3.2 High cost associated with advanced diagnostic tests and innovative therapies |
5 Sweden Heart Failure Diagnostics/Therapeutics Market Trends |
6 Sweden Heart Failure Diagnostics/Therapeutics Market, By Types |
6.1 Sweden Heart Failure Diagnostics/Therapeutics Market, By Therapy |
6.1.1 Overview and Analysis |
6.1.2 Sweden Heart Failure Diagnostics/Therapeutics Market Revenues & Volume, By Therapy, 2021- 2031F |
6.1.3 Sweden Heart Failure Diagnostics/Therapeutics Market Revenues & Volume, By Cardiac Resynchronization Therapy, 2021- 2031F |
6.1.4 Sweden Heart Failure Diagnostics/Therapeutics Market Revenues & Volume, By Ventricular Assist Devices, 2021- 2031F |
6.1.5 Sweden Heart Failure Diagnostics/Therapeutics Market Revenues & Volume, By Counterpulsation Implants, 2021- 2031F |
6.1.6 Sweden Heart Failure Diagnostics/Therapeutics Market Revenues & Volume, By Heart Failure Surgery, 2021- 2031F |
6.1.7 Sweden Heart Failure Diagnostics/Therapeutics Market Revenues & Volume, By Fluid Reduction (Renal Impairment), 2021- 2031F |
6.1.8 Sweden Heart Failure Diagnostics/Therapeutics Market Revenues & Volume, By Neurostimulation, 2021- 2031F |
6.1.9 Sweden Heart Failure Diagnostics/Therapeutics Market Revenues & Volume, By Central Sleep Apnea, 2021- 2031F |
6.1.10 Sweden Heart Failure Diagnostics/Therapeutics Market Revenues & Volume, By Central Sleep Apnea, 2021- 2031F |
6.2 Sweden Heart Failure Diagnostics/Therapeutics Market, By Product |
6.2.1 Overview and Analysis |
6.2.2 Sweden Heart Failure Diagnostics/Therapeutics Market Revenues & Volume, By ECG Systems, 2021- 2031F |
6.2.3 Sweden Heart Failure Diagnostics/Therapeutics Market Revenues & Volume, By Holter Monitors, 2021- 2031F |
6.2.4 Sweden Heart Failure Diagnostics/Therapeutics Market Revenues & Volume, By Event Monitors, 2021- 2031F |
6.2.5 Sweden Heart Failure Diagnostics/Therapeutics Market Revenues & Volume, By Implantable Loop Recorders, 2021- 2031F |
6.3 Sweden Heart Failure Diagnostics/Therapeutics Market, By Tests |
6.3.1 Overview and Analysis |
6.3.2 Sweden Heart Failure Diagnostics/Therapeutics Market Revenues & Volume, By Blood Tests, 2021- 2031F |
6.3.3 Sweden Heart Failure Diagnostics/Therapeutics Market Revenues & Volume, By Chest X Ray, 2021- 2031F |
6.3.4 Sweden Heart Failure Diagnostics/Therapeutics Market Revenues & Volume, By Electrocardiogram, 2021- 2031F |
6.3.5 Sweden Heart Failure Diagnostics/Therapeutics Market Revenues & Volume, By Echocardiogram, 2021- 2031F |
6.3.6 Sweden Heart Failure Diagnostics/Therapeutics Market Revenues & Volume, By Stress Test, 2021- 2031F |
6.3.7 Sweden Heart Failure Diagnostics/Therapeutics Market Revenues & Volume, By Cardiac Computerized Tomography (CT) Scan or Magnetic Resonance Imaging, 2021- 2031F |
6.3.8 Sweden Heart Failure Diagnostics/Therapeutics Market Revenues & Volume, By Myocardial Biopsy, 2021- 2031F |
6.3.9 Sweden Heart Failure Diagnostics/Therapeutics Market Revenues & Volume, By Myocardial Biopsy, 2021- 2031F |
7 Sweden Heart Failure Diagnostics/Therapeutics Market Import-Export Trade Statistics |
7.1 Sweden Heart Failure Diagnostics/Therapeutics Market Export to Major Countries |
7.2 Sweden Heart Failure Diagnostics/Therapeutics Market Imports from Major Countries |
8 Sweden Heart Failure Diagnostics/Therapeutics Market Key Performance Indicators |
8.1 Adoption rate of new diagnostic technologies in the market |
8.2 Percentage of patients receiving timely and appropriate treatment for heart failure |
8.3 Rate of hospital readmissions for heart failure patients |
9 Sweden Heart Failure Diagnostics/Therapeutics Market - Opportunity Assessment |
9.1 Sweden Heart Failure Diagnostics/Therapeutics Market Opportunity Assessment, By Therapy, 2021 & 2031F |
9.2 Sweden Heart Failure Diagnostics/Therapeutics Market Opportunity Assessment, By Product, 2021 & 2031F |
9.3 Sweden Heart Failure Diagnostics/Therapeutics Market Opportunity Assessment, By Tests, 2021 & 2031F |
10 Sweden Heart Failure Diagnostics/Therapeutics Market - Competitive Landscape |
10.1 Sweden Heart Failure Diagnostics/Therapeutics Market Revenue Share, By Companies, 2024 |
10.2 Sweden Heart Failure Diagnostics/Therapeutics Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here